<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5210158 Figure_1-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) EM analysis of cortical synapses derived from WT and MPS-IIIA mice at different ages. The size of synaptic vesicles was quantified from 400-500 vesicles (taken from 5 mice for each genotype at each time point) and expressed as the average of vesicle diameter (nm). The number of synaptic vesicles per synapse was quantified from 20 different images (taken from 5 mice for each genotype at each time point), normalized by the length of synaptic cleft and expressed as % of WT. The synaptic density was measured from 20 different images (taken from 5 mice for each genotype at each time point) as the number of synapses/area(#/500&#956;m2) and expressed as % of WT. Arrows indicate the synaptic cleft, while asterisks indicate abnormal vacuoles</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_1-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) The size of the lysosomal compartment was evaluated by WB (B) analysis in the brain of MPS-IIIA mice at indicated ages. Quantitation of WB by densitometry analysis (ImageJ) was shown (B).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_1-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) The size of the lysosomal compartment was evaluated by IF (C) analysis in the brain of MPS-IIIA mice at indicated ages.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_1-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Extracellular recordings (fEPSPs) in hippocampal brain slices from 6 months-old WT and MPS-IIIA mice. The left panel shows representative fEPSP traces. Summary graphs show the fEPSPs slope as a function of either the applied stimulus intensity or the prevolley amplitude. Data are the average of the values from 9 slices (from 9 mice) in the WT group and 6 slices (from 5 mice) in the MPS-IIIA. *p&lt;0.05, repeated measure ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Synaptic terminal endocytosis was analyzed in WT and MPS-IIIA DIV14 hippocampal neurons by quantification of incorporated FM1-43 dye fluorescence in ~300 individual boutons (taken from 4-5 coverslips for each group). Fluorescence intensities were expressed as arbitrary units (A.F.U.) and displayed both as a distribution and as mean values &#177; s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WT and MPS-IIIA hippocampal neurons (DIV14) were transfected with v-Glut1-pHluorin-mCherry plasmid and synaptic recycling was evaluated by the fluorescence change of the probe from 80-100 individual boutons (taken from 4-5 coverslips for each group). Fluorescence intensity was quantified at each bouton during KCl perfusion, normalized to the fluorescence value obtained upon rapid alkalization (NH4Cl perfusion) and expressed as &#8710;fluorescence (normalized to baseline; &#916;FKCl/&#916;F NH4Cl). Values were displayed both as fluorescence traces (means &#177; s.e.m. at each time frame) and maximum fluorescence after KCl perfusion (means &#177; s.e.m.). Representative panels on the right show the fluorescence intensity change in control neurons (WT). Pseudo-colour was applied to better reveal fluorescence changes. Note that NH4Cl alkalinizes all vesicles revealing the total (recycling + resting) pool in neuronal cells analyzed.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) WT hippocampal neurons at DIV10 were treated with a lysosome inhibitor's cocktail for 3 days. The size of lysosomal compartment was evaluated in both treated and control untreated WT neurons by EM examination. Quantitation analysis was performed on 30 different images.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) Endocytosis (D) in presynaptic boutons from treated and control untreated WT hippocampal neurons were monitored as in (A, B).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) exocytosis (E) in presynaptic boutons from treated and control untreated WT hippocampal neurons were monitored as in (A, B).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_2-F</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) EM analysis of synaptic terminals was performed in treated and control untreated WT neurons. The number of synaptic vesicles per synapse was quantified from ~20 different images (taken from 3 ultrathin sections for each group), normalized by the length of synaptic cleft and expressed as % of WT. Arrows indicate the synaptic cleft.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) VAMP2, SNAP-25 and Syntaxin-1 SNAREs were immunoblotted in WT and MPS-IIIA synaptosomal brain samples at indicated ages. Synapsin-1 was also blotted as a control. Quantitation of WB was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Confocal microscopy images of WT and MPS-IIIA hippocampal neurons (DIV14) double labeled with anti-synapsin-1 (presynaptic marker; red) and either anti-VAMP2 or anti-SNAP25 antibodies (green). The merges (yellow) of confocal images are shown. SNAP25-synapsin-1 and VAMP2-synapsin-1 co-localizations were quantified using the Manders' Colocalization Coefficients (MCC) (ImageJ) and displayed as % (MCC x 100) of Synapsin-1 co-localizing with either SNAP25 or VAMP2 (means &#177; s.e.m. from 15 different images taken from 4-5 coverslips for each group).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) VAMP2 and SNAP-25 protein levels were quantified by immunoblot analysis in WT and MPS-IIIA hippocampal neurons (DIV14) at different times after cycloheximide treatment and expressed as % of remaining protein at T0 (100 %). The proteasome was inhibited as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) SDS-resistant complex levels were evaluated in WT and MPS-IIIA total brain samples at indicated ages by immunoblotting of non-boiled samples with VAMP2 or Syntaxin-1 antibodies. Quantitation of WB was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Total brain lysates were immunoprecipitated with antibodies to Syntaxin-1 and co-immunoprecipitated VAMP2 and SNAP25 proteins were revealed by WB analysis. The levels of immunoprecipitated proteins were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-F</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) &#945;-Synuclein and CSP&#945; were immunoblotted in WT and MPS-IIIA total brain lysates at indicated ages Total protein levels were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_3-G</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) &#945;-Synuclein and CSP&#945; were immunoblotted in WT and MPS-IIIA synaptosomal fractions at indicated ages. Hsc70, an heat shock cognate protein, which forms together with CSP&#945; and SGT (small glutamine-rich tetratricopeptide repeat domain protein) the "chaperon machine" was also blotted. Protein levels were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) WB analysis of LC3 and p62 (an autophagy substrate) was performed on WT and MPS-IIIA brain samples at indicated ages. WB quantitation was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) &#945;-Synuclein was immunoblotted in WT and MPS-IIIA both total and synaptosomal brain fractions at indicated ages after sequential extraction with detergents with increased strength. Soluble (Sol.), lowly insoluble (L. Insol.) and highly insoluble (H. Insol.) forms correspond to the protein solubilized respectively in Triton-X100, SDS 10% and 8M UREA.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Co-immunofluorescence analysis of &#945;-synuclein with SMI-32 in WT and MPS-IIIA hippocampal neurons (DIV14). &#945;-Synuclein synaptic puncta present in a neurite tract of 10&#181;m is showed in a representative enlarged image. Quantification of &#945;-synuclein synaptic puncta was calculated from 30 different enlarged images c.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Confocal analysis of &#945;-synuclein (green) and LAMP1 (red) in WT and MPS-IIIA hippocampal neurons (DIV14). Enlarged merge images are also shown. Co-localization was quantified using the MCC coefficient (ImageJ) and displayed as % (MCC x 100) of &#945;-synuclein co-localizing with LAMP1 (means &#177; s.e.m. from 15 different images taken from 4-5 coverslips for each group).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) CSP&#945; was immunoblotted in WT and MPS-IIIA total brain lysates at indicated ages after sequential extraction with detergents with increased strength as in (B).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-F</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Co-immunofluorescence analysis of CSP&#945; and SMI-32 in DIV14 hippocampal neurons. CSP&#945;- synaptic puncta were quantified as in (C).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-G</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) CSP&#945; protein levels were evaluated by immunoblot analysis in WT and MPS-IIIA hippocampal neurons (DIV14) at different times after cycloheximide treatment and expressed as % of remaining protein at T0 (100 %). The proteasome was inhibited as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-H</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Palmitoylation-dependent shift in the molecular weight of CSP&#945; was evaluated in WT and MPS-IIIA brain samples at indicated ages by immunoblotting CSP&#945; in boiled samples prepared without exposure to sulphydryl agents (beta-mercaptoethanol or dithiothreitol).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-I</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) The protein levels of RPN10 (the regulatory subunit of 26S proteasome) and ubiquitinated proteins formed by Lys-48 (K48) residue linkage (involved in protein degradation via the proteasome) were evaluated in WT and MPS-IIIA brain samples at indicated ages by WB analysis. WB quantitation was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_4-J</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 4-J</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J</infon>
    <passage>
      <offset>0</offset>
      <text>(L) Proteasome activity was evaluated by measuring the chymotrypsin-like activity in WT and MPS-IIIA mouse brain samples at different ages. Proteasome activity was expressed as % of WT activity</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Autophagy was monitored in WT hippocampal neurons treated with the lysosome inhibitor's cocktail for 3 days by immunoblot analysis with anti-LC3 antibodies. As control DIV10 WT neurons were left untreated and monitored by LC3 blot over the three days period. The LC3-II levels quantitation was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Proteasome activity was measured in treated and control untreated WT neurons using pZsProSensor-1 vector (green). Cells were co-stained with anti SMI-32 (blu). Proteasome activity was quantified by measuring the green fluorescence (inversely correlated with proteasome activity) in 10 different cells (taken from 4-5 coverslips for each group) and expressed as fold to WT.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Activation of calpain 2 and caspase-3 proteolytic systems was evaluated by WB measurement of the protein levels of calpain 2 and caspase-3 (both full-length and activated cleaved forms of ~17 KDa) in treated and control untreated WT neurons. Arrow indicated the full-length caspase-3 protein.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) After 3 days-treatment cell lysates from treated and control untreated WT neurons were immunoblotted with &#945;-synuclein and CSP&#945; and protein levels were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Treated and control untreated WT neurons were subjected to &#945;-synuclein (green) and LAMP1 (red) confocal analysis. Enlarged merge images are also shown. Co-localization was quantified using the MCC coefficient (ImageJ) and displayed as % (MCC x 100) of &#945;-synuclein co-localizing with LAMP1 (means &#177; s.e.m. from 15 different images taken from 4-5 coverslips for each group). Cells were also co-stained with anti SMI-32.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-F</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Treated and control untreated WT neurons were subjected to CSP&#945;/SMI-32 co-immunofluorescence. CSP&#945; synaptic puncta present in a neurite tract of 10&#181;m is showed in a representative enlarged image. Quantification of CSP&#945; synaptic puncta was calculated from 30 different enlarged images taken from 4-5 coverslips for each group.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_5-G</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) SDS-resistant complex levels in treated and control untreated WT neurons were evaluated by immunoblotting analysis of non-boiled samples with VAMP2 or SNAP-25 antibodies. The amounts of SNARE complexes were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_6-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) &#945;-Synuclein, CSP&#945;, VAMP2 and SNAP-25 were immunoblotted in total brain homogenates and/or synaptosomal fractions of 1.5 month-old WT (CSP&#945;+/+/&#945;-syn+/+), CSP&#945;-/-, CSP&#945;+/-, &#945;-syn-/-, &#945;-syn+/- and CSP&#945;+/-/&#945;-syn+/-. Synapsin-1 was also blotted as a control. Quantitation of WB in synaptosomal samples was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_6-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) SDS-resistant complex levels were evaluated in brain homogenates derived from mice with indicated genotypes by immunoblotting of non-boiled samples with VAMP2 or Syntaxin-1 antibodies. Quantitation of WB was shown.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_6-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) EM analysis of cortical synapses derived from mice with indicated genotypes. The number of synaptic vesicles per synapse was quantified from 40 different images (taken from 5 different mice for each genotype), normalized by the length of synaptic cleft and expressed as % of WT. The size of synaptic vesicles was quantified from 400-500 vesicles (taken from 5 different mice for each genotype) and expressed as the average of vesicle diameter (nm) Arrows indicate the synaptic cleft.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_6-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Extracellular recordings (fEPSPs) in hippocampal brain slices from 1.5 months-old WT (CSP&#945;+/+/&#945;-syn+/+) and CSP&#945;+/-/&#945;-syn+/- mice. The left panel shows representative fEPSP traces. Summary graphs show the fEPSPs slope as a function of either the applied stimulus intensity or the prevolley amplitude. Data are the average of the values from 5 slices (from 4 mice) in the WT group and 5 slices (from 4 mice) in the CSP&#945;+/-/&#945;-syn+/-. *p&lt;0.05, repeated measure ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_7-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Anti-myc immunostaining in different brain regions derived from 10-months-old MPS-IIIA mice intraventricularly injected with AAV2/9 vectors encoding CSP&#945; under Synapsin-1 promoter (MPS-IIIA-myc-CSP&#945; experimental group). As a control immunostaining was performed in brain sections from 10-months-old MPS-IIIA mice injected with empty AAV2/9 vectors (MPS-IIIA-empty experimental groups). To evaluate co-localization between exogenous CSP&#945; and presynaptic compartment brain sections were also co-stained with anti-myc and anti-synapsin1 antibodies (confocal images are also shown).</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_7-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Anti-myc WB in synaptosomal fractions derived from MPS-IIIA-myc-CSP&#945; mice. As a control WB was performed in samples from 10-months-old WT and MPS-IIIA mice injected with empty AAV2/9 vectors (WT-empty and MPS-IIIA-empty experimental groups). Synaptosomal fractions were also blotted with anti-CSP&#945;.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_7-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) VAMP2, SNAP-25 and Syntaxin-1 were immunoblotted in synaptosomal samples derived from the three experimental groups of mice. Protein levels were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_7-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) The amount of SNARE-complexes was detected in synaptosomal brain samples derived from the three experimental groups of mice by immunoblotting analysis of non-boiled samples with VAMP2, SNAP-25 or Syntaxin-1 antibodies. The amounts of SNARE complexes were quantified.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_7-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Total brain lysates derived from the three experimental groups of mice were immunoprecipitated with Syntaxin-1 antibodies and co-immunoprecipitated VAMP2 and SNAP-25 proteins were revealed by WB.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_8-A</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) EM analysis of cortical and hippocampal synapsis derived from the three experimental groups of mice. Synaptic vesicles number per synapse was quantified from ~40 different images (taken from 5 mice for each group), normalized by the length of synaptic cleft and expressed as % of WT. The synaptic density was measured from 20 different images (taken from 5 mice for each group) as the number of synapses/area(#/500&#956;m2) and expressed as % of WT. Arrows indicate the synaptic cleft while asterisks indicate abnormal vacuoles. Values are means &#177; s.e.m. *P&lt;0.05, Student's t-test: Either MPS-IIIA-empty or MPS-IIIA-myc-CSP&#945; vs WT-empty. Scale bar: 0.2 &#181;m</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_8-B</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Extracellular recordings (fEPSPs) in hippocampal brain slices from WT-empty (n=8), MPS-IIIA-empty (n=5) and MPS-IIIA-myc-CSP&#945; mice (n=5). The upper panel shows representative fEPSP traces. Summary graph shows the fEPSPs slope as a function of the applied stimulus intensity. Data are means &#177; s.e.m.; *P &lt; 0.05 (WT-empty vs MPS-IIIA-empty), #P &lt; 0.05 (MPS-IIIA-myc-CSP&#945; vs. MPS-IIIA-empty), Kruskal-Wallis ANOVA followed by Dunn's test.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_8-C</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Mean distance travelled, maximal speed, immobility time and line crossing during 10 min testing in the open field, divided into 5 minute intervals in WT-empty, MPS-IIIA-empty and MPS-IIIA-myc-CSP&#945; female mice (n=9, n=9, n=7 respectively). Distance, percentage open entries and open time in the elevated plus maze and latency to fall off the wire (*body weight) in the wire hanging test in WT-empty, MPS-IIIA-empty and MPS-IIIA-myc-CSP&#945; male mice (n=10, n=8, n=9 respectively). Values are means &#177; s.e.m; *P &lt; 0.05 (MPS-IIIA-empty vs. WT-empty), #P &lt; 0.05 (MPS-IIIA-myc-CSP&#945; vs. MPS-IIIA-empty), two-way ANOVA for repeated measures for open field measures and t-test for the plus maze and the wire hanging followed by Duncan post-hoc test. Animals' average age was 28&#177;2 weeks.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_8-D</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Neuronal cell death was evaluated in the cerebellum (Calbindin immunostaining) and in different layers of cortex (NeuN immunostaining of frontal cortex) of 10 months-old mice belonging to each experimental group of mice. Number of cells was quantified from 20 different images (taken from 5 mice for each group) and expressed as % of WT. Values are means &#177; s.e.m. *P&lt;0.05, **P&lt;0.001 Student's t-test. Scale bar: 50 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5210158 Figure_8-E</id>
    <infon key="sourcedata_document">2471</infon>
    <infon key="doi">10.15252/emmm.201606965</infon>
    <infon key="pmc_id">5210158</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Kaplan-Meier survival analysis in WT-empty (n=13), MPS-IIIA-empty (n=13) and MPS-IIIA-myc-CSP&#945; (n=13) male mice. The Kaplan-Meier survival curve was analyzed with the Chi-square test. A P value &lt;0.05 was considered to be statistically significant. P= 0.00003 (MPS-IIIA-empty vs WT-empty), P= 0.000776 (MPS-IIIA-myc-CSP&#945; vs MPS-IIIA-empty).</text>
    </passage>
  </document>
</collection>
